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Abbreviations
Anti-SMA Anti-smooth muscle actin
CIPO Chronic intestinal pseudo-obstruction
ENS Enteric nervous system
GINMD Gastrointestinal neuromuscular disorders
HPF High power field
ICC Interstitial cells of Cajal
IL-5 Interleukin-5
Introduction
Chronic intestinal pseudo-obstruction (CIPO) represents a
rare and severe condition characterized by failure of the
intestinal tract to propel its contents normally [1, 2]. The
condition presents with clinical features such as abdominal
pain,vomiting,distendedabdomen,constipation,anddiarrhea
[1, 2]. These symptoms resemble an intestinal mechanical
obstruction in the absence of a demonstrable lesion occluding
thegut.Itisthoughtthatthiscanresultfromdisturbanceofthe
intestinal motor function, supplied by the enteric nervous
system (ENS). The neurons of the ENS are contained in two
groups of ganglia: the myenteric (Auerbach's) and the submu-
cosal (Meissner's) plexuses.
The ENS has the unique ability to control most gut
functions, such as regulating vascular tone, secretion/ab-
sorption, and gut motility [3, 4]. Given these important
functions of the ENS, it is not surprising that damage to
the ENS results in digestive disorders and reduced quality of
life. Human and experimental evidence indicates that in-
flammation can occur in the ENS, resulting in severe intes-
tinal motor impairment. Inflammation of the ENS has
indeed been observed in some cases of CIPO [3, 5, 6].
Many efforts have been made to classify CIPO. Based
on histological examination, CIPO may be categorized as
primary, secondary, or idiopathic in nature [1]. Primary
CIPO can be classified into three major categories of
gastrointestinal neuromuscular disorders (GINMD): mes-
enchymopathies, myopathies, and neuropathies, depend-
ing on the predominant involvement of interstitial cells,
smooth muscle cells, or enteric neurons, respectively [1,
7]. The enteric neuropathies underlying CIPO can be
subdivided into two major entities: (a) degenerative neu-
ropathies, without any evident inflammatory response and
(b) inflammatory neuropathies, referred to as myenteric
ganglionitis [3, 8]. Inflammation within the myenteric
ganglia is a recognized primary cause of CIPO, but the
mechanisms through which the dysfunction occurs and
the mechanisms leading to enteric neuropathies remain
poorly understood [3, 4]. In this case report, we present
thefirstmaleneonatewitheosinophilicmyentericganglionitis
A. H. A. G. Ooms (*):R. R. de Krijger
Department of Pathology, Josephine Nefkens Institute,
Erasmus MC—University Medical Centre,
P.O. 2040, 3000 CA, Rotterdam, The Netherlands
e-mail: a.ooms@erasmusmc.nl
J. Verheij
Department of Pathology, AMC,
Amsterdam, The Netherlands
J. M. Hulst:L. de Ridder
Department of Pediatric Gastroenterology, Erasmus MC—Sophia,
Rotterdam, The Netherlands
J. Vlot
Department of Pediatric Surgery, Erasmus MC—Sophia,
Rotterdam, The Netherlands
C. van der Starre
Neonatal and Pediatric ICU, Erasmus MC—Sophia,
Rotterdam, The Netherlands
Virchows Arch (2012) 460:123–127
DOI 10.1007/s00428-011-1183-xunderlyingCIPOand reporthis successfulrecoveryfollowing
steroid treatment.
Clinical history
A boy was born prematurely at 25 weeks through a primary
Caesarean section, weighing 940 grams (>−2.5 SD). Two
weeks later he suffered from necrotizing enterocolitis for
which he underwent a right hemicolectomy as well as re-
section of 10 cm of jejunum. However, in the months
following surgery, the infant continued to have poor feeding
tolerance with a distended abdomen and severe constipation.
At 6 months of age, the boy weighed 4.1 kg (−2.5 SD),
despite total parental feeding. At 4 months of age, he devel-
oped signs of obstruction (distended abdomen, vomiting,
and gastric retentions) and a laparotomy was performed.
During surgery, there was no stricture at the ileocolonic
anastomosis. Although there was no stricture, a milk curd
was found proximal to the anastomosis and the anastomosis
was resected. Rectal full thickness biopsies were taken to
rule out Hirschsprung's disease. The laboratory results
showed a variable number of eosinophils (0.1×10
9/l to
1.0×10
9/l) and during a short period of time peripheral
eosinophilia was present until treatment started. Laboratory
results further showed a normal amount of serum IgE and
tests for antinuclear and smooth muscle autoantibodies were
negative. Because of the feeding difficulties, the patient was
treated with an amino acid-based infant formula for
4 months. Major improvement of the infant's condition only
occurred after starting anti-inflammatory treatment, using
intravenous prednisone and subsequently oral beclometha-
sone 200 mg three times daily. Within 1–2 weeks after
starting the beclomethasone, enteral nutrition could be in-
creased to complete enteral feeding. After 6 months of
hospitalization, the patient was discharged in good condi-
tion. Follow-up for 7 months after discharge showed that the
patient still needs corticosteroids and steroid-containing
enemas have been added to the therapy during flares of the
gastrointestinal problems, which has a positive effect on his
feeding tolerance. After 18 months of follow-up after hos-
pitalization, the child eats normally and does not need any
medication.
Materials and methods
Patient
Informed consent for publication was obtained from the
parents.
Histological methods
A hemicolectomy specimen as well as 10 cm of jeju-
num was received. Later, full thickness rectal biopsies
were taken during surgery for a pseudo-obstruction as
well as the anastomosis created during the previous
surgery. Histological sections were prepared and exam-
ined by routine methods. Enzyme histochemistry with
acetylcholinesterase was performed on frozen sections of
the biopsies to exclude Hirschsprung's disease. Immu-
nohistochemistry using CD117 was applied on formalin-
fixed paraffin-embedded sections form the resection
specimen to demonstrate the presence of interstitial cells
of Cajal (ICCs). The number of eosinophils per high
power field (HPF, i.e., 400×) was counted in the resec-
tion specimens.
On the same slides, we performed immunohistochemical
analysis with PGP9.5 to demonstrate the presence of enteric
neurons. In addition, we applied anti-smooth muscle actin
(anti-SMA) to demonstrate the presence of a normal layer of
smooth muscle.
Results
Histological findings
In the biopsies, there was no evidence of hypo- or agan-
glionosis. Histological examination of the resected bowel
segment showed a striking presence of eosinophils, espe-
cially in the myenteric plexus with affinity for the neurons
and ganglion cells (range 8–43/HPF; mean 16/HPF)
(Fig. 1). This was located in the ileum as well as in the
colon. There was no significant increase of lymphocytes
surrounding the ganglion cells as in lymphocytic ganglio-
nitis. Retrospectively, histological examination of slides of
the previously removed necrotic bowel also showed the
presence of eosinophils with affinity for the ganglion
cells.
Immunohistochemical findings
Immunohistochemistry with CD117 showed an appar-
ently normal c-Kit labeling pattern, since we found
CD117 positive cells in the colon as well as in the
ileum. These were located in the myenteric plexus, in
the submucosa, and interspersed in the muscle layer.
This indicated a normal number of interstitial cells of
Cajal (Fig. 2a, b). Immunohistochemistry with acetylcholin-
esterase showed a normal amount of acetylcholinesterase-
positive neuronal fibers in the muscularis mucosae and
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(data not shown).
Immunohistochemical analysis with PGP9.5 showed
the presence of an apparently normal number of enteric
neurons, even with the presence of eosinophils in the
immediate vicinity (Fig. 2c). This indicates that the
eosinophilic infiltrate did not lead to degeneration of
the neurons. In addition we used immunohistochemical
analysis with antibodies against smooth muscle actin
(anti-SMA) to show there was a normal amount of
smooth muscle cells (Fig. 2d).
Discussion
We describe the second neonatal case of eosinophilic myen-
teric ganglionitis, causing a rare and highly morbid func-
tional intestinal obstruction syndrome, referred to as CIPO
[2]. This represents a rare syndrome characterized by im-
paired gastrointestinal propulsion, which causes symptoms
of gastrointestinal obstruction, in the absence of any lesion
occluding the intestinal lumen [2]. The intestine depends on
the ENS for its functionally important patterns of movement
[9]. Current evidence indicates that alterations in the ENS,
including functional impairment of neurons, are associated
with uncoordinated motor activities, resulting in altered
transit of intestinal contents potentially leading to CIPO [8].
Schappi et al. [2] described three cases, all female in
contrast to our patient. The three cases described were aged
1 month, 11 and 15 years. The clinical presentation of the
first two patients is similar to our case: vomiting, constipa-
tion, and marked abdominal distension for several days. The
third case had a more acute event. The neonate also
experienced a peripheral blood eosinophilia (1.15×10
9/l) as
did our case before he was treated. However, in our
case there was no elevation in serum IgE, as was
described in the first two cases. Smooth muscle and
antinuclear autoantibodies were weakly positive in the
neonatal case, not described in the second, and negative
in the third case as in our patient. In our patient no
anorectal inflammatory manometry was performed.
In our patient the clinical picture was obscured at first by
necrotizing enterocolitis in this premature infant. However,
after surgery the patient continued to have feeding difficul-
ties. The patient developed signs of a gastrointestinal ob-
struction, but during surgery this turned out to be a pseudo-
obstruction. When examining the bowel specimen, it was
noticed that there was an eosinophilic myenteric ganglioni-
tis. The eosinophils were specifically located around the
ganglion cells, with some scattered eosinophils in the sub-
mucosa and tunica muscularis. In the second and third cases
described by Schappi et al. there seems to be a more exten-
sive involvement of all layers of the bowel, but with a larger
collection of eosinophils around the myenteric plexus. Un-
fortunately, they do not provide a count of the eosinophils.
IL-5, a potent eosinophil chemoattractant, has been sug-
gested as a humoral factor playing a role in gut dysmotility.
IL-5expressionbythe myenteric ganglions was demonstrated
by Schappi et al. in his patients with eosinophilic myenteric
ganglionitis. Unfortunately we did not have the means to
demonstrate IL-5 expression in our patient.
In the neonatal case and the second case of Schappi et al.
Hirschsprung's disease was considered, as was done in our
case. Full thickness rectal biopsies in those children and in
Fig. 1 Hematoxylin/eosin (H/E)-stained sections of full thickness
biopsies from our patient demonstrating the presence of eosinophils
in the myenteric plexus. a Overview of muscular layer with myenteric
plexus. b Detail of myenteric plexus with infiltrating eosinophilic
granulocytes between the ganglion cells and neurons without obvious
cellular destruction
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neurons within the submucosal and myenteric plexus, as
well as a normal acetylcholinesterase staining pattern. In
all cases described as well as in our case, there was no
significant lymphocytic infiltrate.
We applied immunohistochemistry with CD117 antibod-
ies to analyze the number of interstitial cells of Cajal, which
are thought to be required for normal gut motility and are
also implicated in some forms of GINMD. ICCs are found
widespread throughout the gastrointestinal tract, distributed
along a variety of locations. In the colon, distinct networks
can be found in the myenteric plexus and more loosely in
the submucosa. In the small bowel, the same networks can
be found in the myenteric plexus and in addition more
loosely in the deep muscular plexus. Single ICCs can also
be found interspersed between muscle cells in the muscle
layer [10, 11]. CD117 also stains mast cells, which were
excluded by comparing with the H&E and by looking at the
contour of the cell, since mast cells do not have processes
whereas ICCs do [10, 11]. Until now, there are no normal
reference values for the range of ICC numbers when applying
immunohistochemistry. Most reports use immunofluores-
cence on frozen tissue samples instead of immunohistochem-
istryonparaffin-embeddedmaterial[10,11].Itisbelievedthat
immunohistochemistry does not detect all ICCs [10]. There-
fore, we examined our slides for the presence of the ICCs in
the previously named locations, especially in those with the
presence of eosinophils. In addition we used PGP-9.5 and
anti-SMA to demonstrate the presence of a normal amount
of enteric neurons and smooth muscle cells, respectively.
These immunohistochemical stainings also showed a normal
amount of neurons and smooth muscle cells.
By excluding the above-mentioned cells as a cause of the
pseudo-obstruction, it appears more likely that there is a
functional rather than anatomically detectable cause for the
pseudo-obstruction in this patient. However, we cannot en-
tirely exclude this, as we have not performed quantitative
analysis of the enteric neurons. Similar to the patients dem-
onstrated by Schappi et al. there was no clinical improve-
ment in the gastrointestinal dysmotility syndrome with an
amino acid-based formula as the sole source of nutrition for
at least 3 months in our patient as compared to 2 months in
the neonatal case described by Schappi et al. However, all
patients, including our patient, did respond rapidly to ste-
roids [2]. We used the same steroid (beclomethason) in the
same dosage as in the previously published neonatal case.
The other cases were treated with (methyl)prednisolone and
azathioprine. Our patient could tolerate complete enteral
feeding within 1–2w e e k s .I nc o n t r a s tt ot h ep r e v i o u s l y
published patients, our patient is completely without medi-
cation after 18 months of follow-up, not requiring a main-
tenance dose of steroids.
In conclusion, this case illustrates that a GINMD, such as
myenteric ganglionitis, should be considered in patients
with CIPO, since it may be treated with an elemental diet
and steroids.
Fig. 2 Immunohistochemistry
on sections of the resection
specimen from our patient. a, b
Overview (a; 40×) and detail
(b; 200×) of a slide form the
bowel resection stained for
CD117, highlighting the ICCs,
with an apparently normal
distribution and number. c
Detail (200×) of the myenteric
plexus stained for PGP9.5,
highlighting the neurons. An
apparently normal number can
be appreciated. d Overview
(40×) of a slide stained for
anti-SMA, in which a normal
pattern of smooth muscle cells
can be seen
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